And semaglutide specifically has been shown to reduce neuropathic pain in diabetic rats by inhibiting spinal neuroinflammation [8], and a 2025 review in the Korean Journal of Pain concluded that GLP-1 receptor agonists have real potential in neuropathic pain management [20]
This value is determined by High-Performance Liquid Chromatography (HPLC), which separates the target BPC-157 peptide from any synthesis-related impurities (e.g., failed sequences, truncated peptides, or residual reagents)
JAMA 304 , 18031810 (2010)
For patients whose primary goal is weight management alongside diabetes control, NICE guidance (NG28) supports considering SGLT2 inhibitors, which are generally weight-neutral or beneficial
Cagrilintide is a long-acting amylin analog that works on the satiety pathway, the signal that tells your brain you are full and keeps you full, so appetite quiets and weight loss becomes sustainable rather than a constant fight